BNR Competitors & Alternatives
Compare Burning Rock Biotech Ltd with similar stocks in the same industry
Diagnostics & Research
BNR
Main Stock$15.00
Tradestie Score
36
Market Cap
$93.35M
Revenue Growth
-0.1%
Analyst Upside
-73.1%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OPK
Opko Health Inc.
|
$1.38
|
$1.23B | - | 46 | Compare |
|
NEO
NeoGenomics, Inc.
|
$16.20
|
$1.13B | - | 47 | Compare |
|
CDNA
CareDx, Inc.
|
$63.12
|
$798.40M | 30.6 | 35 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$21.47
|
$719.31M | - | 51 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$22.16
|
$718.62M | - | 64 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$32.76
|
$667.77M | - | 45 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$15.80
|
$612.76M | - | 50 | Compare |
|
NBP
NBP
|
$1.32
|
$161.82M | - | 49 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$3.74
|
$85.47M | - | 72 | Compare |
|
PASG
Passage Bio, Inc. Common Stock
|
$4.55
|
$25.84M | - | 46 | Compare |
More BNR Analysis
Data updated: Oct 12, 2026 | Industry: Diagnostics & Research (SIC 8071)
39 stocks in this industry